StimLabs Achieves ISO 13485:2016 Certification, Solidifying Leadership Position Among Industry

ROSWELL, Ga., Sept. 24, 2025 /PRNewswire/ — StimLabs, a pioneering regenerative science company, is proud to announce it has received its ISO 13485:2016 Certificate of Registration, a internationally recognized standard for comprehensive medical device quality management systems.

This certification marks a significant milestone in StimLabs’ ongoing commitment to operational excellence, patient safety, and quality-driven innovation. Combined with the company’s existing accreditation by the American Association of Tissue Banks (AATB), this achievement places StimLabs among an elite group of organizations that meet the highest standards in both tissue banking and medical device design, development and manufacturing. In Georgia, StimLabs is the only wound care device company that holds both AATB accreditation and ISO 13485:2016 certification.

“Achieving ISO 13485:2016 certification is more than a regulatory accomplishment – it’s a testament to our team’s unwavering commitment to quality and the patients we serve,” said StimLabs Founder and CEO, John Daniel. “This globally recognized standard enhances StimLabs’ ability to achieve sustainable, scalable growth into new markets and strengthens our position as a trusted partner to hospitals, healthcare providers, and distributors – making it easier to expand patient access to advanced solutions.”

With this achievement, StimLabs continues to set the standard in regenerative science by delivering innovative technologies with the safety, quality, and integrity that the industry and patients demand.

For more information about StimLabs and its advanced solutions, visit www.stimlabs.com.

ABOUT STIMLABS
StimLabs LLC was founded in 2015 with the mission to innovate with purpose to transform lives through regenerative science. Comprised of industry leaders, StimLabs is dedicated to offering patients the best possible care while recognizing the urgency of providing solutions in areas with unmet needs. StimLabs has a comprehensive product portfolio addressing various clinical applications and has established a strong intellectual property catalog. Committed to delivering superior products, StimLabs is a trusted partner to physicians and patients alike.

Media Contact:
media@stimlabs.com
470-616-0958

View original content to download multimedia:https://www.prnewswire.com/news-releases/stimlabs-achieves-iso-134852016-certification-solidifying-leadership-position-among-industry-302564898.html

SOURCE StimLabs